Tech Company Financing Transactions
Endotronix Funding Round
On 9/15/2018, Endotronix raised $45 million in Series D financing from LSP BioVentures, Aperture Venture Partners and BioVentures Investors.
Transaction Overview
Company Name
Announced On
9/15/2018
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series D
Investors
LSP BioVentures (Lead Investor) (Fouad Azzam)
SV Health Investors (Paul LaViolette)
Proceeds Purpose
This financing supports the commercialization of the Cordella Heart Failure System (Cordella System) and clinical development of the Cordella Pulmonary Artery Sensor (Cordella Sensor) through CE Marking and FDA Premarket Approval (PMA).
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
815 Ogden Ave.
Lisle, IL 60532
USA
Lisle, IL 60532
USA
Phone
Website
Email Address
Overview
Digital health solutions to enhance quality of life, improve outcomes and lower costs, especially for the millions of people battling cardiovascular diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Harry Rowland
Chief Medical Officer
Katrin Leadley
Chief Technical Officer
Michael Nagy
VP - Bus. Development
Nicolas Chronos
VP - Manufacturing
Michael Dilworth
VP - R & D
David Morrow
Browse more venture capital transactions:
Prev: 9/15/2018: Responsive venture capital transaction
Next: 9/15/2018: Anki venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs